Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 7 » Supplement 1

Noradrenergic symptom cluster in depression

Authors Montgomery S, Briley M

Published Date May 2011 Volume 2011:7(Supplement 1) Pages 1—2

DOI http://dx.doi.org/10.2147/NDT.S19611

Published 31 May 2011

Stuart Montgomery1, Mike Briley2
1Imperial College School of Medicine, London, UK; 2NeuroBiz Consulting and Communication, Castres, France
Depression is characterized by a wide range of diverse symptoms, the severity of which can be quantified by various depression rating scales, such as the Montgomery Asberg Depression Rating Scale. Analyses of the individual items of this scale in patients treated with the selective serotonin reuptake inhibitors (SSRIs) have shown that not all items respond equally or with the same time of onset of improvement (Table 1).1,2 The items which respond less well or more slowly with SSRIs include lassitude, loss of energy, retardation of thoughts or actions, as well as concentration difficulties and loss of alertness. The loss of interest or pleasure that depressed patients experience (anhedonia) also responds poorly to SSRIs, and patients often complain of emotional indifference or blunting. Certain sleep difficulties are sometimes worsened by SSRIs. Appetite loss can be aggravated by certain SSRIs, an effect which can be made worse by nausea at the beginning of treatment.

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Choking risk among psychiatric inpatients

Nagamine T

Neuropsychiatric Disease and Treatment 2011, 7:381-382

Published Date: 20 June 2011

The noradrenergic symptom cluster: clinical expression and neuropharmacology

Blier P, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:15-20

Published Date: 3 June 2011

The increasing burden of depression

Lépine J-P, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:3-7

Published Date: 31 May 2011

The importance of norepinephrine in depression

Moret C, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:9-13

Published Date: 31 May 2011

Improvement of the noradrenergic symptom cluster following treatment with milnacipran

Kasper S, Meshkat D, Kutzelnigg A

Neuropsychiatric Disease and Treatment 2011, 7:21-27

Published Date: 31 May 2011

Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities

Miho Takenoshita, Tomoko Sato, Yuichi Kato, et al

Neuropsychiatric Disease and Treatment 2010, 6:699-705

Published Date: 13 October 2010

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors

Mike Briley, Chantal Moret

Neuropsychiatric Disease and Treatment 2010, 6:647-655

Published Date: 23 September 2010

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran

Peter Hofmann

Neuropsychiatric Disease and Treatment 2010, 6:9-15

Published Date: 25 August 2010

Antidepressant therapy with milnacipran and venlafaxine

Lucilla Mansuy

Neuropsychiatric Disease and Treatment 2010, 6:17-22

Published Date: 25 August 2010

Milnacipran: a unique antidepressant?

Siegfried Kasper, Gerald Pail

Neuropsychiatric Disease and Treatment 2010, 6:23-31

Published Date: 25 August 2010

Milnacipran: recent findings in depression

Guest editors: Stuart Montgomery (London, UK) and Mike Briley (Castres, France)

Neuropsychiatric Disease and Treatment 2010, 6:0-0

Published Date: 24 August 2010

Editorial Foreword - Milnacipran: recent findings in depression

Stuart Montgomery, Mike Briley

Neuropsychiatric Disease and Treatment 2010, 6:1-2

Published Date: 24 August 2010

Readers of this article also read:

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders

Yong C, Wang ZX, Zhang X, Shi XM, Ni ZJ, Fu H, Ding GS, Fu ZR, Yin H

International Journal of Nanomedicine 2014, 9:985-993

Published Date: 17 February 2014

Update on pediatric dystonias: etiology, epidemiology, and management

Fernández-Alvarez E, Nardocci N

Degenerative Neurological and Neuromuscular Disease 2012, 2:29-41

Published Date: 12 April 2012

Self-assembled mPEG–PCL-g–PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro

Shi S, Zhu XC, Guo QF, Wang YJ, Zuo T, Luo F, Qian ZY

International Journal of Nanomedicine 2012, 7:1749-1759

Published Date: 30 March 2012

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial

Nakakura S, Tabuchi H, Baba Y, Maruiwa F, Ando N, Kanamoto T, Kiuchi Y

Clinical Ophthalmology 2012, 6:369-375

Published Date: 6 March 2012

A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil

Felekis T, Asproudis I, Katsanos K, Tsianos EV

Clinical Ophthalmology 2011, 5:1443-1445

Published Date: 7 October 2011

The first report on intermediate-term outcome of Ex-PRESS® glaucoma filtration device implanted under scleral flap in Japanese patients

Sugiyama T, Shibata M, Kojima S, Ueki M, Ikeda T

Clinical Ophthalmology 2011, 5:1063-1066

Published Date: 29 July 2011

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

Greater osteoblast proliferation on anodized nanotubular titanium upon electrical stimulation

Batur Ercan, Thomas J Webster

International Journal of Nanomedicine 2008, 3:477-485

Published Date: 14 August 2008